MoneyWorks4Me

Clarification from Arvind Remedies

06 Apr 2015 Evaluate

With reference to the Increase in Price, Arvind Remedies has Clarified that the Company has been so far complying with all the listing requirements including furnishing information as per Clause 36 that were having bearing on the operations/ performance of the company and as regards the recent price increase, it is hereby clarified we are not aware of any new information or event as reason for the same.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..